<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02494843</url>
  </required_header>
  <id_info>
    <org_study_id>14025</org_study_id>
    <nct_id>NCT02494843</nct_id>
  </id_info>
  <brief_title>Dynamic Effects of Online HDF on Cardiac Function and Myocardial Perfusion Utilising Cardiac MRI (CAMRID)</brief_title>
  <acronym>CAMRID</acronym>
  <official_title>Dynamic Effects of Online HDF on Cardiac Function and Myocardial Perfusion Utilising Cardiac MRI (CAMRID)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fresenius Medical Care Deutschland GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterise, in detail, the cardiac structure, function and&#xD;
      perfusion of those on haemodialysis and haemodiafiltration, comparing the two modalities to&#xD;
      ascertain if haemodiafiltration provides relative myocardial protection compared to&#xD;
      conventional haemodialysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trial Configuration: Non-blinded crossover pilot study Setting: Secondary care Sample size&#xD;
      estimate: This is a pilot study therefore power calculations are not appropriate. A group&#xD;
      size of 12 participants has been selected for feasibility.&#xD;
&#xD;
      Number of participants: 12 patients to complete study Description of interventions&#xD;
&#xD;
        -  6 sessions of conventional haemodialysis each lasting 4 hours&#xD;
&#xD;
        -  6 sessions of online haemodiafiltration each lasting 4 hours&#xD;
&#xD;
        -  2 sessions of Cardiac MRI each lasting 6 hours in total to take place around 6th session&#xD;
           of dialysis Randomisation and blinding: This is an open study. Statistical methods: All&#xD;
           continuous variables will be tested for normality. The primary and continuous secondary&#xD;
           endpoints will be compared between the two modalities using a paired t test or Wilcoxon&#xD;
           signed rank test as appropriate. The association between categorical variables will be&#xD;
           tested using the Chi squared or Fischer's Exact test. An alpha error at 0.05 will be&#xD;
           judged as significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">December 31, 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change in global cardiac perfusion (ml/min/100g) between conventional HD and HDF</measure>
    <time_frame>2 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change in segmental cardiac perfusion during conventional HD and HDF</measure>
    <time_frame>2 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change in global and segmental cardiac function as measured by phase-contrast MRI</measure>
    <time_frame>2 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum markers of cardiac damage, renal, liver function, clotting, full blood count</measure>
    <time_frame>2 weeks</time_frame>
    <description>Bloods collected at the end of 2 week study period on the scan days on HD and HDF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reported tolerability of cardiac MRI scanning whilst having dialysis</measure>
    <time_frame>On 2 MRI study days</time_frame>
    <description>On 2 MRI study days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Other Postprocedural Cardiac Functional Disturbances</condition>
  <condition>Myocardial Perfusion</condition>
  <arm_group>
    <arm_group_label>Online haemodiafiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Haemodialysis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>online Hemodiafiltration</intervention_name>
    <description>Effects of high efficiency online hemodiafiltration on cardiac structure, function and myocardial perfusion were compared with standard haemodialysis.</description>
    <arm_group_label>Haemodialysis</arm_group_label>
    <arm_group_label>Online haemodiafiltration</arm_group_label>
    <other_name>Hemodiafiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hemodialysis</intervention_name>
    <description>Effects of high efficiency online hemodiafiltration on cardiac structure, function and myocardial perfusion were compared with standard haemodialysis.</description>
    <arm_group_label>Haemodialysis</arm_group_label>
    <arm_group_label>Online haemodiafiltration</arm_group_label>
    <other_name>Haemodialysis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-75 years&#xD;
&#xD;
          -  Able to give informed consent&#xD;
&#xD;
          -  CKD5 on chronic haemodialysis&#xD;
&#xD;
          -  Receiving dialysis via an arteriovenous fistula&#xD;
&#xD;
          -  Must be able to follow simple instruction in English (on safety grounds for MRI scans)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Change in ideal dry weight in 4 weeks prior to recruitment&#xD;
&#xD;
          -  Instability on dialysis in 4 weeks prior to recruitment leading to either:&#xD;
&#xD;
               -  Emergency medical attention&#xD;
&#xD;
               -  Infusion of additional fluid&#xD;
&#xD;
               -  Loss in consciousness&#xD;
&#xD;
               -  Arrhythmia&#xD;
&#xD;
               -  Chest pain&#xD;
&#xD;
          -  Dialysed via a synthetic line or graft&#xD;
&#xD;
          -  Qa &lt; 500ml/min&#xD;
&#xD;
          -  NYHA Stage IV heart failure&#xD;
&#xD;
          -  Active infection or malignancy&#xD;
&#xD;
          -  Contraindication to MRI scanning including claustrophobia&#xD;
&#xD;
          -  Mental incapacity to consent&#xD;
&#xD;
          -  Pregnancy or planning pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 7, 2015</study_first_submitted>
  <study_first_submitted_qc>July 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2015</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

